Cape Argus – 9 August 2011
Improved breast cancer screening can save lives
Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment
Taylor L, Basro S, Apffelstaedt JP, Baatjes K. Breast Cancer Res Treat. 2011 Aug;129(1):99-106. Epub 2011 Jun 23. PMID: 21698411 [PubMed - in process] http://www.ncbi.nlm.nih.gov/pubmed/21698411
Southern Suburbs Tatler – 5 November 2010
Business Women’s Association Day
Surgical mammography reporting in a limited resource environment
Mouton JP, Apffelstaedt J, Baatjes K. World J Surg. 2010 Nov;34(11):2530-6. PMID: 0577769 [PubMed - indexed for MEDLINE]
Must breast care delivery models from resource-rich environments be applied to resource-limited environments?
Apffelstaedt J, Mouton JP, Baatjes K. World J Surg. 2010 Nov;34(11):2782-3; author reply 2784-5. No abstract available. PMID: 20703461 [PubMed - indexed for MEDLINE]
Cape Argus – 21 Oct 2010
Cancer survivor is now "Bosom Buddy"
Sowetan – 13 Oct 2010
Genetic profiling
Shape Online – 8 Oct 2010
If you find a lump....
Financial Mail – 7 Oct 2010
Breast cancer awareness
Surgeon-read screening mammography: an analysis of 11,948 examinations
Apffelstaedt JP, Steenkamp V, Baatjes KJ. Ann Surg Oncol. 2010 Oct;17 Suppl 3:249-54. Epub 2010 Sep 19. PMID: 20853042 [PubMed - indexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/20853042
Foschini Club – 1 Oct 2010
Survival Mode
South African Journal of Gynaecological Oncology, SAJGO
Reflections on the USPSTF Breast Screening Recommendations from a South African Perspective
Breast cancer in young women in a limited-resource environment
Basro S, Apffelstaedt JP. World J Surg. 2010 Jul;34(7):1427-33. PMID: 19997919 [PubMed - indexed for MEDLINE]
Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial
Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R. J Clin Oncol. 2010 Feb 20;28(6):967-75. Epub 2010 Jan 11. PMID: 20065185 [PubMed - indexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/20065185
Performance data of screening mammography at a dedicated breast health centre
Apffelstaedt JP, Steenkamp V, Baatjes K. S Afr Med J. 2008 Dec;98(12):950-3.PMID: 19374072 [PubMed - indexed for MEDLINE Performance data of screening mammography at a dedicated breast health centre
Counseling for male BRCA mutation carriers – a review
Mohamad HB, Apffelstaedt JP. Counseling for male BRCA mutation carriers - a review. Breast. 2008 Oct;17(5):441-50. Epub 2008 Jul 26. PMID: 18657973 [PubMed - in process]
Guideline implementation for breast healthcare in low- and middle-income countries : diagnosis resource allocation.
Shyyan R, Sener SF, Anderson BO, Fernández Garrote LM, Hortobágyi GN, Ibarra JA Jr, Ljung BM, Sancho-Garnier H, Stalsberg H; on behalf of the Breast Health Global Initiative Diagnosis Panel The Breast Health Global Initiative Diagnosis Panel members included Gaurav [...]
Conservative management of breast cancer in the elderly in a developing country
Wasserman LJ, Apffelstaedt JP, Odendaal Jde V. Conservative management of breast cancer in the elderly in a developing country. World J Surg Oncol. 2007 Oct 1;5:108. PMID: 17908323 [PubMed - indexed for MEDLINE]
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Tripathy D, Lichinitzer M, Lazarev A, MacLachlan SA, Apffelstaedt J, Budde M, Bergstrom B; MF 4434 Study Group. Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial. [...]
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJ. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal [...]
Locally advanced breast cancer in developing countries: the place of surgery
Apffelstaedt JP. Locally advanced breast cancer in developing countries: the place of surgery. World J Surg. 2003 Aug;27(8):917-20. Epub 2003 Jun 6. Review. PMID: 12784145 [PubMed - indexed for MEDLINE]
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.
Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Chaudri-Ross H, Lang R, Wyld P, Bhatnagar A. [...]
Limited surgery and tamoxifen in the treatment of elderly breast cancer patients.
Odendaal Jde V, Apffelstaedt JP. Limited surgery and tamoxifen in the treatment of elderly breast cancer patients. World J Surg. 2003 Feb;27(2):125-9. PMID: 12616422 [PubMed - indexed for MEDLINE]
Indications and complications of latissimus dorsi myocutaneous flaps in oncologic breast surgery
Apffelstaedt J. Indications and complications of latissimus dorsi myocutaneous flaps in oncologic breast surgery. World J Surg. 2002 Sep;26(9):1088-93. Epub 2002 Jun 21. PMID: 12209237 [PubMed - indexed for MEDLINE]